(c) 2024 PillSync.com

Carbamazepine 200 MG Oral Tablet Tegretol

INDICATIONS AND USAGE Epilepsy Tegretol is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of Tegretol as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by Tegretol (see PRECAUTIONS, General). Trigeminal Neuralgia Tegretol is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.

Novartis Pharmaceuticals Corporation


5 years ago OVAL PINK Tegretol 27 27 Carbamazepine 200 MG Oral Tablet Tegretol

OVAL PINK Tegretol 27 27

HOW SUPPLIED Chewable Tablets 100 mg - round, red-speckled, pink, single-scored (imprinted Tegretol on one side and 52 twice on the scored side) Bottles of 100………………………………………………………………………………….NDC 0078-0492-05 Unit Dose (blister pack) Box of 100 (strips of 10)……………………………………………………………………....NDC 0078-0492-35 Do not store above 30°C (86°F). Protect from light and moisture. Dispense in tight, light-resistant container (USP). Meets USP Dissolution Test 1. Tablets 200 mg - capsule-shaped, pink, single-scored (imprinted Tegretol on one side and 27 twice on the partially scored side) Bottles of 100.............................................................................................................................NDC 0078-0509-05 Bottles of 60...............................................................................................................................NDC 0078-0509-20 Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). [See USP Controlled Room Temperature]. Protect from moisture. Dispense in tight container (USP). Meets USP Dissolution Test 2. XR Tablets 100 mg - round, yellow, coated (imprinted “T” on one side and 100 mg on the other), release portal on one side Bottles of 100.............................................................................................................................NDC 0078-0510-05 XR Tablets 200 mg - round, pink, coated (imprinted “T” on one side and 200 mg on the other), release portal on one side Bottles of 100.............................................................................................................................NDC 0078-0511-05 XR Tablets 400 mg - round, brown, coated (imprinted “T” on one side and 400 mg on the other), release portal on one side Bottles of 100.............................................................................................................................NDC 0078-0512-05 Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense in tight container (USP). Suspension 100 mg/5 mL (teaspoon) – yellow-orange, citrus-vanilla flavored Bottles of 450 mL.......................................................................................................................................NDC 0078-0508-83 Shake well before using. Do not store above 30°C (86°F). Dispense in tight, light -resistant container (USP). *Thorazine ® is a registered trademark of GlaxoSmithKline. T2023-61 September 2023


More pills like OVAL Tegretol 27 27












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site